|
1
|
World Health Organisation Tobacco Free
Initiative. Oslo, Norway. WHO Workshop on Advancing Knowledge on
Regulating Tobacco Products; February 2000;
|
|
2
|
Rogot E and Murray JL: Smoking and causes
of death among U.S. veterans: 16 years of observation. Public
Health Rep. 95:213–222. 1980.PubMed/NCBI
|
|
3
|
Howard G, Wagenknecht LE, Burke GL, et al:
Cigarette smoking and progression of atherosclerosis: The
Atherosclerosis Risk in Communities (ARIC) Study. JAMA.
279:119–124. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang CQ, Xu L, Lam TH, Lin JM, Cheng KK
and Thomas GN: Smoking cessation and carotid atherosclerosis: the
Guangzhou Biobank Cohort Study-CVD. J Epidemiol Community Health.
64:1004–1009. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rodgman A, Smith CJ and Perfetti TA: The
composition of cigarette smoke: a retrospective, with emphasis on
polycyclic components. Hum Exp Toxicol. 19:573–595. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Baird WM, Hooven LA and Mahadevan B:
Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and
mechanism of action. Environ Mol Mutagen. 45:106–114. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shi Z, Dragin N, Miller ML, et al: Oral
benzo[a]pyrene-induced cancer: two distinct types in different
target organs depend on the mouse Cyp1 genotype. Int J Cancer.
127:2334–2350. 2010.
|
|
8
|
Griendling KK, Sorescu D and Ushio-Fukai
M: NAD(P)H oxidase: role in cardiovascular biology and disease.
Circ Res. 86:494–501. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ross R: Atherosclerosis is an inflammatory
disease. Am Heart J. 138:S419–S420. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Libby P: Inflammation in atherosclerosis.
Nature. 420:868–874. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li DW, Liu ZQ, Wei J, Liu Y and Hu LS:
Contribution of endothelial progenitor cells to neovascularization
(Review). Int J Mol Med. 30:1000–1006. 2012.PubMed/NCBI
|
|
12
|
Rabelink TJ, de Boer HC, de Koning EJ and
van Zonneveld AJ: Endothelial progenitor cells: more than an
inflammatory response? Arterioscler Thromb Vasc Biol. 24:834–838.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hristov M, Zernecke A, Bidzhekov K, et al:
Importance of CXC chemokine receptor 2 in the homing of human
peripheral blood endothelial progenitor cells to sites of arterial
injury. Circ Res. 100:590–597. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hutter R, Carrick FE, Valdiviezo C, et al:
Vascular endothelial growth factor regulates reendothelialization
and neointima formation in a mouse model of arterial injury.
Circulation. 110:2430–2435. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hill JM, Zalos G, Halcox JP, et al:
Circulating endothelial progenitor cells, vascular function, and
cardiovascular risk. N Engl J Med. 348:593–600. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ramos KS, Zhang Y, Sadhu DN and Chapkin
RS: The induction of proliferative smooth muscle cell phenotypes by
benzo[a]pyrene is characterized by up-regulation of inositol
phospholipid metabolism and c-Ha-ras gene expression. Arch Biochem
Biophys. 332:213–222. 1996.
|
|
17
|
Curfs DM, Lutgens E, Gijbels MJ, Kockx MM,
Daemen M and van Schooten FJ: Chronic exposure to the carcinogenic
compound benzo[a]pyrene induces larger and phenotypically different
atherosclerotic plaques in ApoE-knockout mice. Am J Pathol.
164:101–108. 2004.PubMed/NCBI
|
|
18
|
Smaniotto S, Martins-Neto AA, Dardenne M
and Savino W: Growth hormone is a modulator of lymphocyte
migration. Neuroimmunomodulation. 18:309–313. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kleinman HK and Martin GR: Matrigel:
basement membrane matrix with biological activity. Semin Cancer
Biol. 15:378–386. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cominacini L, Garbin U, Pasini AF, et al:
Oxidized low-density lipoprotein increases the production of
intracellular reactive oxygen species in endothelial cells:
inhibitory effect of lacidipine. J Hypertens. 16:1913–1919. 1998.
View Article : Google Scholar
|
|
21
|
Heid CA, Stevens J, Livak KJ and Williams
PM: Real time quantitative PCR. Genome Res. 6:986–994. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gibson UE, Heid CA and Williams PM: A
novel method for real time quantitative RT-PCR. Genome Res.
6:995–1001. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ziegler-Heitbrock HW, Sternsdorf T, Liese
J, et al: Pyrrolidine dithiocarbamate inhibits NF-kappa B
mobilization and TNF production in human monocytes. J Immunol.
151:6986–6993. 1993.PubMed/NCBI
|
|
24
|
Kalka C, Masuda H, Takahashi T, et al:
Transplantation of ex vivo expanded endothelial progenitor cells
for therapeutic neovascularization. Proc Natl Acad Sci USA.
97:3422–3427. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hur J, Yoon CH, Kim HS, et al:
Characterization of two types of endothelial progenitor cells and
their different contributions to neovasculogenesis. Arterioscler
Thromb Vasc Biol. 24:288–293. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Grunewald M, Avraham I, Dor Y, et al:
VEGF-induced adult neovascularization: recruitment, retention, and
role of accessory cells. Cell. 124:175–189. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yamahara K and Itoh H: Potential use of
endothelial progenitor cells for regeneration of the vasculature.
Ther Adv Cardiovasc Dis. 3:17–27. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sirker AA, Astroulakis ZM and Hill JM:
Vascular progenitor cells and translational research: the role of
endothelial and smooth muscle progenitor cells in endogenous
arterial remodelling in the adult. Clin Sci. 116:283–299. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Peichev M, Naiyer AJ, Pereira D, et al:
Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells
identifies a population of functional endothelial precursors.
Blood. 95:952–958. 2000.
|
|
30
|
Urbich C and Dimmeler S: Endothelial
progenitor cells: characterization and role in vascular biology.
Circ Res. 95:343–353. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Salvatore P, Casamassimi A, Sommese L, et
al: Detrimental effects of Bartonella henselae are
counteracted by L-arginine and nitric oxide in human endothelial
progenitor cells. Proc Natl Acad Sci USA. 105:9427–9432. 2008.
|
|
32
|
Asahara T and Kawamoto A: Endothelial
progenitor cells for postnatal vasculogenesis. Am J Physiol Cell
Physiol. 287:C572–C579. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kamihata H, Matsubara H, Nishiue T, et al:
Implantation of bone marrow mononuclear cells into ischemic
myocardium enhances collateral perfusion and regional function via
side supply of angioblasts, angiogenic ligands, and cytokines.
Circulation. 104:1046–1052. 2001. View Article : Google Scholar
|
|
34
|
Szmitko PE, Fedak PW, Weisel RD, Stewart
DJ, Kutryk MJ and Verma S: Endothelial progenitor cells: new hope
for a broken heart. Circulation. 107:3093–3100. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Werner N, Kosiol S, Schiegl T, et al:
Circulating endothelial progenitor cells and cardiovascular
outcomes. N Engl J Med. 353:999–1007. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vasa M, Fichtlscherer S, Aicher A, et al:
Number and migratory activity of circulating endothelial progenitor
cells inversely correlate with risk factors for coronary artery
disease. Circ Res. 89:E1–E7. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tepper OM, Galiano RD, Capla JM, et al:
Human endothelial progenitor cells from type II diabetics exhibit
impaired proliferation, adhesion, and incorporation into vascular
structures. Circulation. 106:2781–2786. 2002. View Article : Google Scholar
|
|
38
|
Fadini GP, De Kreutzenberg SV, Coracina A,
et al: Circulating CD34+ cells, metabolic syndrome, and
cardiovascular risk. Eur Heart J. 27:2247–2255. 2006.PubMed/NCBI
|
|
39
|
Heeschen C, Lehmann R, Honold J, et al:
Profoundly reduced neovascularization capacity of bone marrow
mononuclear cells derived from patients with chronic ischemic heart
disease. Circulation. 109:1615–1622. 2004. View Article : Google Scholar
|
|
40
|
Cai H and Harrison DG: Endothelial
dysfunction in cardiovascular diseases: the role of oxidant stress.
Circ Res. 87:840–844. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sundaresan M, Yu ZX, Ferrans VJ, Irani K
and Finkel T: Requirement for generation of
H2O2 for platelet-derived growth factor
signal transduction. Science. 270:296–299. 1995.
|
|
42
|
Pryor WA, Prier DG and Church DF:
Electron-spin resonance study of mainstream and sidestream
cigarette smoke: nature of the free radicals in gas-phase smoke and
in cigarette tar. Environ Health Perspect. 47:345–355. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Pryor WA, Stone K, Zang LY and Bermudez E:
Fractionation of aqueous cigarette tar extracts: fractions that
contain the tar radical cause DNA damage. Chem Res Toxicol.
11:441–448. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zang LY, Stone K and Pryor WA: Detection
of free radicals in aqueous extracts of cigarette tar by electron
spin resonance. Free Radic Biol Med. 19:161–167. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Haddad JJ: Oxygen sensing and
oxidant/redox-related pathways. Biochem Biophys Res Commun.
316:969–977. 2004. View Article : Google Scholar : PubMed/NCBI
|
